European research suggests that combining three simple interventions—vitamin D and omega-3 supplementation plus home exercise—could dramatically reduce the risk for cancer in healthy older adults. The DO-HEALTH trial is the first to test these three interventions together and has shown that they have an additive effect on cancer prevention. At…

Researchers from the Johns Hopkins Kimmel Cancer Center and the Johns Hopkins University School of Medicine have developed a computational method to assess which patients with metastatic triple-negative breast cancer could benefit from immunotherapy. The work, published in the Proceedings of the National Academy of Sciences, aims to develop a more…

A team of researchers from the University of Basel, Switzerland, and colleagues in Germany has demonstrated the benefit of specific exercise that can reduce a common side-effect of cancer treatment, chemotherapy-induced peripheral neuropathy (CIPN). As many as 90% of patients receiving therapies such as oxaliplatin or vinca alkaloids experience a…

Many patients who receive hematopoietic stem cell transplantation (HSCT) for blood cancer suffer from stress related to their treatments. Now, a new phone-based positive psychology program called Positive Affect for the Transplantation of Hematopoietic stem cells intervention (PATH), has shown that it can alleviate the stress these patients experience as…

Researchers at the Francis Crick Institute, the National Cancer Institute (NCI) of the U.S. National Institutes of Health, and Aalborg University in Denmark have discovered that vitamin D can increase the amount of a certain type of gut bacteria, providing better immunity to cancer.  Vitamin D is essential for human…

Just four-and-a-half minutes of vigorous activity during daily tasks could reduce the risk of some cancers by up to 32%, according to a large-scale observational study that used data from wearables. Vigorous Intermittent Lifestyle Physical Activity, or ‘VILPA’, was associated with a substantially lower cancer risk in those who engaged…

Cardiorespiratory fitness could be important for reducing a man’s risk of developing and dying from certain cancers, Scandinavian research suggests. The study in JAMA Network Open linked higher cardiorespiratory fitness with a reduced risk of dying from colon, lung, and prostate cancer—the three most common cancers in men. Greater fitness…

A new study led by researchers from Imperial College London and published in eClinicalMedcine suggests that higher consumption of ultra-processed foods may be linked to increased risks of developing and dying from cancer. Ultra-processed foods include fizzy drinks, mass-produced package breads, many ready meal and the majority of breakfast cereals.…

Researchers from Israel have shown that applying acupuncture during surgery for gynecologic cancers significantly reduces high-intensity postoperative pain, while preoperative acupressure can decrease anxiety. Patients undergoing surgery for gynecologic cancers often experience anxiety both before and after surgery, which has in turn been associated with an increased risk for pain…

Adolescents and young adults (AYAs) who have survived cancer are at increased risk for cardiovascular disease (CVD) in later life that may be disproportionately associated with sociodemographic and modifiable risk factors, shows data from the National Health Interview Survey. “CVD risk in childhood and older adult cancer survivors has been…

Researchers at UT Southwestern Simmons Cancer Center report that lactate, a metabolic byproduct produced by cells during strenuous exercise, may rejuvenate immune cells that fight cancer. Their findings, published in Nature Communications, could eventually be used to develop new strategies to augment the anti-tumor effect of cancer immunotherapies. “The lactate that…

A trial in people at high risk of hereditary cancers has shown a major preventive effect from resistant starch, which is found in foods such as oats, breakfast cereal, cooked and cooled pasta or rice, peas, beans, and slightly green bananas. “We hypothesize that resistant starch reduces production of secondary…

Precision oncology newcomer, Scorpion Therapeutics has announced it will collaborate with big pharma company AstraZeneca, in a deal that will see the two companies work together to develop cancer therapies against previously “undruggable” targets. The collaboration will focus on hard-to-target proteins called transcription factors (TFs) that control gene expression and…

Research from Umeå University, Sweden, suggests taking antibiotics can increase colon cancer risk, with greater risks linked to longer treatment periods, likely due to an adverse impact on the gut microbiome. The researchers say there is a clear link between such long-term antibiotic use and an increased risk of developing…

A new precision drug, currently under development in the U.K., that stops cancer from repairing its DNA has shown promise in an early-stage clinical trial, highlighting the potential of a new class of drugs known as ATR inhibitors. The drug candidate, recently tested in humans for the first time, was…